RLAY
RLAY
US75943R1023
Relay Therapeutics, Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
3.92B EUR
4.09B EUR
1.88B EUR
1.47B EUR
Enterprise Value
2.93B EUR
4B EUR
1.71B EUR
1.42B EUR
Valuation Multiples
Trailing P/E
--
--
--
--
Forward P/E
-10.95x
--
--
--
Price to Sales
378.58x
395.05x
176.33x
191.6x
Price to Book
4.39x
4.59x
2.93x
2.59x
EV/Revenue
283.57x
386.3x
160.12x
184.89x
EV/EBITDA
-9.52x
--
--
--
Price to FCF (P/FCF)
--
--
--
--
EV/FCF
--
--
--
--
FCF Yield
-3.04%
-5.19%
-11.33%
-11.03%
ende